What is the recommended therapeutic hypothermia protocol for a term infant with moderate-to-severe hypoxic‑ischemic encephalopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Therapeutic Hypothermia Protocol for Hypoxic-Ischemic Encephalopathy

For term infants with moderate-to-severe HIE, initiate therapeutic hypothermia to a target temperature of 33.5°C within 6 hours of birth and maintain for 72 hours. 1

Core Protocol Parameters

Target temperature: 33.5°C (not deeper)

  • Duration: 72 hours of cooling
  • Timing: Must begin within 6 hours of birth
  • Rewarming: Slow, at 0.5°C per hour 2

The 2026 Pediatrics guidelines 1 are definitive here, based on an NICHD optimization trial that was stopped early due to increased mortality with deeper (32°C) or longer (120 hours) cooling protocols. This establishes 33.5°C for 72 hours as the evidence-based standard.

Patient Selection Criteria

Two requirements must be met:

1. Biochemical Evidence of Hypoxic-Ischemic Event

  • Cord blood gas showing severe acidosis, OR
  • Blood gas within first hour showing acidosis
  • Critical point: Advocate for cord gases on ALL depressed neonates 1

2. Clinical Evidence of Moderate-to-Severe Encephalopathy

  • Neurological examination demonstrating moderate or severe encephalopathy, OR
  • Clinical seizures
  • No sentinel event required to initiate cooling 1

Gestational Age Requirements

  • ≥36 weeks: Standard indication 1
  • 35 0/7 to 35 6/7 weeks: Limited evidence; requires detailed parental discussion of risks/benefits with clear documentation 1
  • <35 weeks: Insufficient evidence; not recommended outside research protocols

Extended Time Window (6-24 Hours)

If cooling cannot be initiated within 6 hours, late cooling between 6-24 hours may be considered after parental discussion 1. The evidence shows:

  • 76% probability of any reduction in death or disability
  • Small effect size (71% probability of 1% reduction, 64% for 2% reduction, 56% for 3% reduction)
  • Requires 96 hours of cooling when initiated late (based on preclinical data) 1

This is not ideal but better than no intervention - prioritize early identification to avoid this scenario.

Transport Considerations

Use servo-controlled cooling during transport whenever possible 1. Passive cooling carries significant overcooling risk. If servo-control unavailable:

  • Develop strict protocols for rectal temperature monitoring
  • Monitor vital signs continuously
  • Transition to active servo-controlled cooling immediately upon arrival 1

Approximately one-third of HIE infants don't reach cooling centers within 6 hours 1, making transport cooling protocols essential for regional systems.

What NOT to Do

Do not cool infants with mild HIE - insufficient evidence, should only occur in research settings with informed consent 1

Do not use adjuvant therapies outside research protocols 1

Avoid hyperthermia in ALL cases of possible HIE, even when therapeutic hypothermia is not administered 1

Required Infrastructure

Centers offering therapeutic hypothermia must provide 1:

  • Mechanical ventilation capability
  • Continuous physiologic and biochemical monitoring
  • MRI prior to discharge
  • Continuous EEG (preferred) or aEEG for seizure detection
  • 24/7 neurology consultation access (minimum via telemedicine)
  • Written protocols with outcome monitoring
  • Neurodevelopmental follow-up programs

Medication Adjustments During Cooling

Hypothermia alters drug metabolism 1:

  • Gentamicin: 5 mg/kg/dose every 36 hours (vs standard 24h) with therapeutic drug monitoring
  • Morphine: Decreased clearance; use low-dose maintenance with close sedation monitoring
  • Midazolam: Increased clearance if co-administered with phenobarbital

Follow-Up Requirements

All cooled infants require enrollment in neurodevelopmental follow-up programs 1. Intensity based on:

  • HIE severity
  • Brain MRI results
  • Feeding difficulties
  • Medication needs

Refer to Early Intervention Services and Developmental Pediatrics specialists 1.

Common Pitfalls

  1. Waiting for sentinel event identification - not required, delays treatment 1
  2. Passive cooling without monitoring - high overcooling risk 1
  3. Cooling mild HIE "just in case" - no evidence, potential harm 1
  4. Inadequate family communication - use lay language, written materials, involve all caregivers, repeat information 1
  5. Missing cord gases - advocate proactively for ALL depressed neonates 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.